Characterization of behavioral response to amphetamine, tyrosine hydroxylase levels, and dopamine receptor levels in neurokinin 3 receptor knockout mice-Reference-Cited by-同舟云学术

Characterization of behavioral response to amphetamine, tyrosine hydroxylase levels, and dopamine receptor levels in neurokinin 3 receptor knockout mice

Published:2008-09 Issue:5-6 Volume:19 Page:518-529
ISSN:0955-8810
Container-title:Behavioural Pharmacology
language:en
Short-container-title:

Author:

Nordquist Rebecca E.,Savignac Helene,Pauly-Evers Meike,Walker Gaby,Knoflach Fred,Borroni Edilio,Glaentzlin Patricia,Bohrmann Bernd,Messer Jurg,Ozmen Laurence,Albientz Anita,Spooren Will

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Psychiatry and Mental health,Pharmacology

Reference37 articles.

1. Dopamine D1 receptor-stimulated release of acetylcholine in rat striatum is mediated indirectly by activation of striatal neurokinin1 receptors;Anderson;J Pharmacol Exp Ther,1994

2. Effects of acute versus chronic treatment with typical or atypical antipsychotics on D-amphetamine-induced sensorimotor gating deficits in rats;Andersen;Psychopharmacology,2001

3. Intranigral antagonism of neurokinin 1 and 3 receptors reduces intrastriatal dopamine D1 receptor-stimulated locomotion in the rat;Bishop;Brain Res,2004

4. Antischizophrenic drugs: chronic treatment elevates dopamine receptor binding in brain;Burt;Science,1977

5. Quantitative peptidomics in mice: effect of cocaine treatment;Che;J Mol Neurosci,2006

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Update on Oxytocin, Phosphodiesterase, Neurokinin, Glycine as a Therapeutic Approach in the Treatment of Schizophrenia;CNS & Neurological Disorders - Drug Targets;2023-08

2. l-DOPA-induced behavioral sensitization of motor activity in the MPTP-treated common marmoset as a Parkinson's disease model;Pharmacology Biochemistry and Behavior;2014-12

3. Progress in the development of neurokinin 3 modulators for the treatment of schizophrenia: molecule development and clinical progress;Future Medicinal Chemistry;2013-09

4. Will Modulation of Neuropeptide Receptors Produce the Next Generation of Antipsychotic Drugs? A Focus on the Neurokinin and Neurotensin Systems;Targets and Emerging Therapies for Schizophrenia;2012-06-24

5. Uncovering Novel Reproductive Defects in Neurokinin B Receptor Null Mice: Closing the Gap Between Mice and Men;Endocrinology;2012-03-01